AMGN ▼ -1.8% - Amgen Inc.
$AMGN AMGN - IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
24-OCT-2026 10:30 AM ET
Share this post
More filings for $AMGN
AMGN ▼ -1.8% - Amgen Inc.Oct 24, 2026AMGN ▼ -0.7% - Amgen Inc.Oct 23, 2026AMGN ▲ +3.4% - Amgen Inc.Oct 20, 2026AMGN ▲ +0.9% - Amgen Inc.Oct 20, 2026AMGN ▲ +0.9% - Amgen Inc.Oct 20, 2026AMGN ▼ -0.4% - Amgen Inc.Sep 28, 2026
View full $AMGN filing history →💬 Comments
Loading comments…
Leave a comment
